HBM Healthcare Investments: Revision history

20 August 2022

• curprev 01:4301:43, 20 August 2022 95.149.241.133 talk 33,175 bytes +11 No edit summary undo

22 July 2022

• curprev 16:1716:17, 22 July 2022 >Louis 33,164 bytes +42 No edit summary undo

8 June 2022

• curprev 10:2110:21, 8 June 2022 >George 33,122 bytes +37 No edit summary undo
• curprev 08:4708:47, 8 June 2022 172.18.0.3 talk 33,085 bytes +245 →Notes undo
• curprev 08:4308:43, 8 June 2022 172.18.0.3 talk 32,840 bytes −1 →Asset allocation undo
• curprev 08:3608:36, 8 June 2022 >George 32,841 bytes +209 →Asset allocation undo
• curprev 08:3408:34, 8 June 2022 >George 32,632 bytes +1 →Performance: Stabilising after a more difficult year undo
• curprev 08:3308:33, 8 June 2022 >George 32,631 bytes +88 →Performance: Stabilising after a more difficult year undo
• curprev 08:3108:31, 8 June 2022 >George 32,543 bytes +73 →Performance: Stabilising after a more difficult year undo
• curprev 08:2908:29, 8 June 2022 >George 32,470 bytes +87 →Performance: Stabilising after a more difficult year undo
• curprev 08:2808:28, 8 June 2022 >George 32,383 bytes +47 →Dividends: Consistent growth record maintained undo
• curprev 08:2608:26, 8 June 2022 >George 32,336 bytes +87 →Discount: Potential to narrow after difficult spell undo
• curprev 08:2508:25, 8 June 2022 >George 32,249 bytes +38 →Capital structure: Diverse base but thinner volumes undo
• curprev 08:2508:25, 8 June 2022 >George 32,211 bytes +1,862 →Summary undo

7 June 2022

• curprev 21:5321:53, 7 June 2022 >George 30,349 bytes +11 →The board undo
• curprev 21:5221:52, 7 June 2022 >George 30,338 bytes +6,071 →Summary undo
• curprev 21:4121:41, 7 June 2022 >George 24,267 bytes +24,267 Created page with "== Summary == HBM Healthcare Investments (HBMN) posted its first NAV loss in a decade for FY22 (ended 31 March), but, as shown in the chart below, its long-term performance record remains very impressive. The recent fall in the share price from a premium to a discount to NAV (10.0% at 20 May) could present an opportunity for long-term investors who, like HBMN’s management team, remain convinced of the long-term opportunities afforded by careful investment in the health..."